Error: Could not add to watchlist. X

Sunovion Pharmaceuticals Inc

+ Watchlist
SEPR:US
Acquired
SEPR:US was acquired by 4005:JP
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
1.88
Market Cap (USD)
-
Shares Outstanding (m)
110.988
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Large Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Sunovion Pharmaceuticals, Inc. manufactures pharmaceutical products. The Company develops and produces medicines for the treatment of central nervous system and respiratory ailments such as schizophrenia, depression, epilepsy, neuropathic pain, and insomnia. Sunovion Pharmaceuticals serves customers in the United States.
ADDRESS
84 Waterford Drive
Marlborough, MA 01752
United States
PHONE
1-508-481-6700
  • Robert Gregorio
    Exec VP/CAO
  • Antony Loebel
    Exec VP/Chief Medical Officer
  • Albert P Parker "Al"
    Exec VP/General Counsel/Secy
  • Hiroyuki Baba
    Executive VP
  • Matthew D'Ambrosio
    Senior VP/Chief Compliance Ofcr
Show More